ATS 2024 Final Program

Click on the session title to view the speakers

162

MONDAY • MAY 20

P1311 Pulmonary Carcinoid Tumorlets in Pulmonary Hypertension Associated With Pulmonary Fibrosis P1312 Thyroid Troubles: A Case of Acute Heart Failure Due to Epoprostenol-Induced Thyrotoxicosis P1313 Distinguishing Dyspnea: Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension P1314 Pulmonary Capillary Hemangiomatosis Due to Mitomycin Therapy in a Patient Diagnosed With HIV-Related Pulmonary Arterial Hypertension P1315 Amyloidosis: An Uncommon Cause Pulmonary Hypertension P1316 Right Ventricular Failure Following Progression of Pulmonary Metastatic Burden in Primary Breast Cancer P1317 Rare Case of Pulmonary Hypertension Masquerading as Worsening Seizure Disorder P1318 Under Pressure: A Case of Systemic Capillary Leak Syndrome and Monoclonal Gammopathy of Undetermined Significance With Pulmonary Arterial Hypertension P1319 Pulmonary Arterial Hypertension as a Consequence of Graft Versus Host Disease P1320 Pulmonary Hypertension Secondary to Congenital Unilateral Absence of the Right Pulmonary Artery P1321 A Rare Case of Vitamin C Deficiency Causing Pulmonary Hypertension P1322 The Dark Side of Right Heart Catheterization: A Rare and Devastating Complication P1323 A Case of Symptomatic Chronic Thromboembolic Disease Treated With Pulmonary Thromboendarterectomy P1324 Intravenous Selexipag Uptitration for Decompensated Right Ventricular Failure in Pulmonary Arterial Hypertension: A Novel Approach P1325 A Case Series of Porto Pulmonary Htn With Hepatopulmonary Syndrome P1326 Platypnea-Orthodeoxia: A Case of Possible Portopulmonary Hypertension Complicated by Atrial Septal Defect (ASD)

CLINICAL THEMATIC POSTER SESSION

B58 WE ARE ON A MISSION (BEACH): HOT CASES IN PULMONARY HYPERTENSION 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1301 Changes in Cardiopulmonary Exercise Test Parameters in Response to Phosphodiesterase 5 Inhibitors (PD5i) In Patients With Mild Pulmonary Hypertension: Case Series P1302 The Right Restoration: Recovery of Right Heart Failure Based on Echocardiogram Evaluation With Cessation of Methamphetamine Use and Treatment, a Case Series P1303 Unique Presentation of Pulmonary Veno-occlusive Disease in Patient Whose Mother Had Familial Pulmonary Arterial Hypertension P1304 Improvement in PAH After Semaglutide-induced Weight Loss P1305 “Pop n’ Drop”: Two Cases of Recreational Amyl Nitrite Use Among Patients With Pulmonary Arterial Hypertension on Phosphodiesterase-5 Inhibitors Leading to Syncope P1306 Acute Right Ventricular Failure: More Than Meets the Eye P1307 Fibrosing Mediastinitis Resulting in Unilateral Pulmonary Artery Hypertension P1308 Pulmonary Hypertension Due to Unilateral Absence of Pulmonary Artery: A Series of 2 Cases P1309 Obstructive Pulmonary Hypertension Secondary to Pulmonary Artery Constriction From Aggressive Mediastinal Lymphoma P1310 Severe Pulmonary Hypertension With Acute Hypoxic Respiratory Failure Following Carfilzomib Administration for Refractory Multiple Myeloma San Diego Convention Center Area K (Hall H, Ground Level)

ATS 2024 Conference Program • San Diego, CA